BIOMAT Database Logo BIOMAT Database Logo

Rifampicin as tuberculostatic agent. Preliminary communication. 1968

C Virchow, and J Flemming

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

C Virchow, and J Flemming
Tryptophane as a tuberculostatic agent.
December 1958, Experientia,
C Virchow, and J Flemming
Rifampicin as cytotoxic agent for cholangiocarcinoma: preliminary report of seven cases.
January 1991, Journal of cancer research and clinical oncology,
C Virchow, and J Flemming
A liposomal contrast agent. Preliminary communication.
September 1988, Investigative radiology,
C Virchow, and J Flemming
The in vivo distribution of the 99mTc-labelled albumin and gelatin microspheres of a tuberculostatic agent, rifampicin.
February 1991, Bollettino chimico farmaceutico,
C Virchow, and J Flemming
[Furazolidone: new therapeutic agent for giardiasis. (Preliminary communication)].
October 1960, Prensa medica argentina,
C Virchow, and J Flemming
Montmorillonite-Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic.
February 2023, Pharmaceutics,
C Virchow, and J Flemming
[Presence of antibodies against rifampicin in patients under tuberculostatic treatment].
January 1981, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
C Virchow, and J Flemming
A thyroid blocking agent as a cause of endemic goitre in Tasmania: preliminary communication.
September 1955, The Medical journal of Australia,
C Virchow, and J Flemming
Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent.
January 1997, Journal of biomaterials science. Polymer edition,
C Virchow, and J Flemming
A tuberculostatic agent present in animal tissues.
January 1951, American review of tuberculosis,
Copied contents to your clipboard!